Medtronic's AneuRx stent approved by FDA

New York, March 27 - Medtronic, Inc. said it received approval from the Food and Drug Administration for its AneuRx AAAdvantage abdominal aortic aneurysm stent graft with Xcelerant delivery system.

AneuRx AAAdvantage is a minimally-invasive device that treats dangerous bulges in the aorta, the body's largest artery, that can rupture without warning.

Medtronic noted that 1.2 million people in the United States are estimated to have abdominal aortic aneurysm - of which only 15% are diagnosed and less than half treated.

Stent graft therapy is intended to provide a minimally invasive alternative to complex open surgical repair.

Medtronic is a Minneapolis-based medical device company.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.